Literature DB >> 1958444

The influence of co-administered organic acids on the kinetics and dynamics of frusemide.

D K Sommers1, E C Meyer, J Moncrieff.   

Abstract

1. This study examines the effects of pretreatment with probenecid with and without pyrazinamide on the elimination kinetics and diuretic action of frusemide. 2. Six normal male volunteers received 40 mg frusemide i.v. on three occasions; i.e. once on its own and twice after pretreatment with 2 g probenecid with and without 3 g pyrazinamide. Both these latter drugs were administered orally 3 h before frusemide administration thereby attempting optimal suppression of proximal tubular secretion. Urinary losses were replaced i.v. with isovolumetric amounts of normal saline while insensible losses were compensated for by taking tap water orally. 3. The mean cumulative urinary frusemide excretion was significantly and similarly decreased by pretreatment with probenecid (34.9%) and probenecid plus pyrazinamide (33.6%), but the mean total volume of diuresis and the mean cumulative urinary sodium excretion did not differ significantly between treatments over the 5 h period. 4. The diuretic efficiency of frusemide was significantly increased with probenecid pretreatment during the first 90 min period after frusemide administration. Furthermore, in the first 30 min after administration the percent sodium fractional excretion was higher after pretreatment with probenecid even though the mean frusemide excretion rate was more than three times with frusemide alone than with probenecid-frusemide (374.4 micrograms min-1 vs 119.1 micrograms min-1). Pretreatment with probenecid results in a higher concentration on the peritubular or blood side of the tubules and these results lead us to question the unconditional acceptance of a luminal site of action for the loop diuretics. Alternatively, probenecid may act in some other way to increase the effects of frusemide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958444      PMCID: PMC1368611          DOI: 10.1111/j.1365-2125.1991.tb03936.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Probenecid inhibition of bumetanide-induced natriuresis in the dog.

Authors:  S D Holland; H E Williamson
Journal:  Proc Soc Exp Biol Med       Date:  1979-07

2.  Comparison of renal tubular transport of urate and PAH in water snakes: evidence for differences in mechanisms and sites of transport.

Authors:  W H Dantzler
Journal:  Comp Biochem Physiol       Date:  1970-06-01

Review 3.  Pharmacodynamic considerations in the use of diuretics.

Authors:  D C Brater
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

4.  Effects of probenecid on furosemide response.

Authors:  D C Brater
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

Review 5.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

6.  The time course of delivery of furosemide into urine: an independent determinant of overall response.

Authors:  S Kaojarern; B Day; D C Brater
Journal:  Kidney Int       Date:  1982-07       Impact factor: 10.612

7.  Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide.

Authors:  J B Hook; H E Williamson
Journal:  J Pharmacol Exp Ther       Date:  1965-09       Impact factor: 4.030

8.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

Authors:  M M Hammarlund; B Odlind; L K Paalzow
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

9.  Probenecid potentiates the hyperglycaemic effect but reduces the diuretic effect of frusemide in mice.

Authors:  P E Sandström
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

10.  Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.

Authors:  G Alván; L Helleday; A Lindholm; E Sanz; T Villén
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

View more
  5 in total

1.  The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.

Authors:  V Pichette; D Geadah; P du Souich
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

3.  Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.

Authors:  G Alván; G Paintaud; S A Eckernäs; A Grahnén
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Renal drug transporters and their significance in drug-drug interactions.

Authors:  Jia Yin; Joanne Wang
Journal:  Acta Pharm Sin B       Date:  2016-08-09       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.